Table 2.
Distribution of XDR, MDR and Non-MDR samples among Pseudomonas aeruginosa clinical isolates obtained from different clinical sources
| Clinical source | Total number of isolates | XDR isolates no. (%) | MDR isolates no. (%) | Non-MDR (Sensitive) isolates no. (%) | χ2/MC | P value |
|---|---|---|---|---|---|---|
| Burn | 27 | 17 (63%) | 8 (29.6%) | 2 (7.4%) | 4.06 | 0.131 |
| Wound | 17 | 15 (88.2%) | 1 (5.9%) | 1 (5.9%) | 2.41 | 0.299 |
| Urine | 16 | 15 (93.8%) | 0 (0%) | 1 (6.3%) | 4.75 | 0.09 |
| Sputum | 6 | 3 (50%) | 3 (50%) | 0 (0%) | 4.43 | 0.109 |
| Blood | 2 | 2 (100%) | 0 (0%) | 0 (0%) | 0.66 | 0.719 |
| Pus | 2 | 1 (50%) | 1 (50%) | 0 (0%) | 1.39 | 0.498 |
| Total no. of isolates | 70 | 53 (75.7%) | 13 (18.6%) | 4 (5.7%) |
XDR Extensively-drug resistant, MDR Multidrug-resistant, Non-MDR Non- multidrug resistant, MC Monte Carlo test, χ2 Chi-Square test, P probability